FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Geert Blijham

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Aneuploidy

Physiology

Cell Divisions

Co-author Network

Publications

TOP 3
Maartje H J Swennen; Geert J M G Van Der Heijden; Geert H Blijham; Cor Kalkman
Career stage and work setting create different barriers for evidence-based medicine.
Roland Repp; Heidi H van Ojik; Thomas Valerius; Gerard Groenewegen; G Wieland; C Oetzel; Bernhard Stockmeyer; W Becker; M Eisenhut; H Steininger; YM Deo; Geert H Blijham; Joachim R Kalden; Jan G J van de Winkel; Martin Gramatzki
Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.
Paul Chr De Jong; Marinus A Blankenstein; J W R Nortier; Peter Slee; Joost van de Ven; Joost M H H van Gorp; Johannes R J Elbers; Margriet E I Schipper; Geert H Blijham; Jos H H Thijssen; Qing Lu; Danijela Jelovac; Angela Brodie
The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Geert Blijham (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Maartje H J Swennen; Geert J M G Van Der Heijden; Geert H Blijham; Cor Kalkman
Career stage and work setting create different barriers for evidence-based medicine.
Journal of evaluation in clinical practice 2011;17(4):775-85.
2003: Roland Repp; Heidi H van Ojik; Thomas Valerius; Gerard Groenewegen; G Wieland; C Oetzel; Bernhard Stockmeyer; W Becker; M Eisenhut; H Steininger; YM Deo; Geert H Blijham; Joachim R Kalden; Jan G J van de Winkel; Martin Gramatzki
Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer.
British journal of cancer 2003;89(12):2234-43.
2003: Paul Chr De Jong; Marinus A Blankenstein; J W R Nortier; Peter Slee; Joost van de Ven; Joost M H H van Gorp; Johannes R J Elbers; Margriet E I Schipper; Geert H Blijham; Jos H H Thijssen; Qing Lu; Danijela Jelovac; Angela Brodie
The relationship between aromatase in primary breast tumors and response to treatment with aromatase inhibitors in advanced disease.
The Journal of steroid biochemistry and molecular biology 2003;87(2-3):149-55.
2003: Jacques A Wils; Geert H Blijham; Th Wagener; J De Greve; R L H Jansen; T C Kok; J W R Nortier; Harry Bleiberg; ML Couvreur; Bruno Genicot; Benoît Baron
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group.
European journal of cancer (Oxford, England : 1990) 2003;39(3):346-52.
2002: Shiuw H Han; John M H de Klerk; Suzy Tan; Alfred D van het Schip; Bert H Derksen; Aalt van Dijk; Cas L J J Kruitwagen; Geert H Blijham; Peter P van Rijk; Bernard A Zonnenberg
The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(9):1150-6.
2002: Claus-Henning Köhne; D Cunningham; B Glimelius; Geert H Blijham; E Aranda; W Scheithauer; P Rougier; M Palmer; Jacques A Wils; Benoît Baron; F Pignatti; Patrick Schöffski; S Micheel; F Di Costanzo; H Hecker
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):308-17.
2001: Angela Brodie; Qing Lu; Brian Long; Amy M Fulton; T Chen; N Macpherson; P C DeJong; Marinus A Blankenstein; J W R Nortier; Peter Slee; Joost van de Ven; Joost M H H van Gorp; Johannes R J Elbers; M E Schipper; Geert H Blijham; Jos H H Thijssen
Aromatase and COX-2 expression in human breast cancers.
The Journal of steroid biochemistry and molecular biology 2001;79(1-5):41-7.
2001: J R J de Leeuw; Alexander de Graeff; Wynand J G Ros; Geert H Blijham; Gerrit Jan Hordijk; J A M Winnubst
Prediction of depression 6 months to 3 years after treatment of head and neck cancer.
Head & neck 2001;23(10):892-8.
2001: Paul Chr De Jong; Marinus A Blankenstein; Joost van de Ven; J W R Nortier; Geert H Blijham; Jos H H Thijssen
Importance of local aromatase activity in hormone-dependent breast cancer: a review.
Breast (Edinburgh, Scotland) 2001;10(2):91-9.
2001: Pierre Hupperets; Jacques A Wils; L Volovics; Leo J Schouten; MM Fickers; H N Bron; Jos J Jager; J M B V de Jong; Geert H Blijham
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up.
Breast (Edinburgh, Scotland) 2001;10(1):35-7.
2001: Alexander de Graeff; J R J de Leeuw; Wynand J G Ros; Gerrit Jan Hordijk; Geert H Blijham; J A M Winnubst
Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer.
European journal of cancer (Oxford, England : 1990) 2001;37(3):332-9.
2000: J R J de Leeuw; Alexander de Graeff; Wynand J G Ros; Geert H Blijham; Gerrit Jan Hordijk; J A M Winnubst
Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support.
Head & neck 2000;22(8):799-807.
2000: Alexander de Graeff; J R J de Leeuw; Wynand J G Ros; Gerrit Jan Hordijk; Geert H Blijham; J A M Winnubst
Pretreatment factors predicting quality of life after treatment for head and neck cancer.
Head & neck 2000;22(4):398-407.
2000: RI Lalisang; E E Voest; Jacques A Wils; J W Nortier; F L G Erdkamp; H F P Hillen; Jacob Wals; Harry C Schouten; Geert H Blijham
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer.
British journal of cancer 2000;82(12):1914-9.
2000: Marijke Bontenbal; J W R Nortier; Louk V A M Beex; P Bakker; Pierre Hupperets; Marianne A Nooij; H van Veelen; G Vreugdenhil; D J Richel; Geert H Blijham
[Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology].
Nederlands tijdschrift voor geneeskunde 2000;144(21):984-9.
2000: F J M Grosfeld; Cornelis J M Lips; Frits A Beemer; Geert H Blijham; JM Quirijnen; M P Mastenbroek; Herman F J ten Kroode
Distress in MEN 2 family members and partners prior to DNA test disclosure. Multiple endocrine neoplasia type 2.
American journal of medical genetics 2000;91(1):1-7.
2000: Jos J Jager; R L H Jansen; Jan-Willem Arends; Susan R Joosten-Achjanie; L Volovics; Leo J Schouten; J M B V de Jong; M F Meyenfeldt; Geert H Blijham
Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer.
Anticancer research 2000;20(2B):1269-75.
2000: MJ Verhaar-Langereis; Vivian Bongers; John M H de Klerk; Aalt van Dijk; Geert H Blijham; Bernard A Zonnenberg
Interferon-alpha induced changes in CEA expression in patients with CEA-producing tumours.
European journal of nuclear medicine 2000;27(2):209-13.
2000: MJ Verhaar-Langereis; Bernard A Zonnenberg; John M H de Klerk; Geert H Blijham
Radioimmunodiagnosis and therapy.
Cancer treatment reviews 2000;26(1):3-10.
2000: J R J de Leeuw; Alexander de Graeff; Wynand J G Ros; Gerrit Jan Hordijk; Geert H Blijham; J A M Winnubst
Negative and positive influences of social support on depression in patients with head and neck cancer: a prospective study.
Psycho-oncology 2000;9(1):20-8.
2000: Alexander de Graeff; J R J de Leeuw; Wynand J G Ros; Gerrit Jan Hordijk; Geert H Blijham; J A M Winnubst
Long-term quality of life of patients with head and neck cancer.
The Laryngoscope 2000;110(1):98-106.
1999: Geert H Blijham
How will the hospital survive in the next millennium.
The Netherlands journal of medicine 1999;55(6):257-60.
1999: Paul Chr De Jong; Geert H Blijham
New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
The Netherlands journal of medicine 1999;55(2):50-8.
1999: Alexander de Graeff; Rob J De Leeuw; Wynand J G Ros; Gerrit Jan Hordijk; Jan J Battermann; Geert H Blijham; J A M Winnubst
A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy.
Head & neck 1999;21(4):291-6.
1999: M J Verhaar; CA Damen; Bernard A Zonnenberg; Geert H Blijham
In vitro upregulation of carcinoembryonic antigen expression by combinations of cytokines.
Cancer letters 1999;139(1):67-73.
1999: S H Han; B A Zonneberg; John M H de Klerk; JM Quirijnen; Alfred D van het Schip; Aalt van Dijk; Geert H Blijham; Peter P van Rijk
186Re-etidronate in breast cancer patients with metastatic bone pain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(4):639-42.
1999: Jos J Jager; L Volovics; Leo J Schouten; J M B V de Jong; Pierre Hupperets; M F von Meyenfeldt; B Schutte; Geert H Blijham
Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;50(3):267-75.
1999: Eric Van Cutsem; Geert H Blijham
Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group.
Seminars in oncology 1999;26(1 Suppl 5):13-20.
1999: Arjan W Griffioen; CA Damen; Kevin H Mayo; AF Barendsz-Janson; Stefano Martinotti; Geert H Blijham; Gerard Groenewegen
Angiogenesis inhibitors overcome tumor induced endothelial cell anergy.
International journal of cancer. Journal international du cancer 1999;80(2):315-9.
1999: M M Tinnemans; Marie-Hélène Lenders; Guul P M ten Velde; Geert H Blijham; Frans C S Ramaekers; B Schutte
Prognostic value of cytokinetic parameters in lung cancer after in vivo bromodeoxyuridine labelling.
Anticancer research 1999;19(1A):531-4.
1999: Alexander de Graeff; J R J de Leeuw; Wynand J G Ros; Gerrit Jan Hordijk; Geert H Blijham; J A M Winnubst
A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy.
Oral oncology 1999;35(1):27-32.
1999: Eric Van Cutsem; D Cunningham; W W Ten Bokkel Huinink; C J Punt; C G Alexopoulos; L Dirix; M Symann; Geert H Blijham; P Cholet; G Fillet; C Van Groeningen; J M Vannetzel; F Levi; G Panagos; C Unger; Jacques A Wils; C Cote; C Blanc; P Hérait; Harry Bleiberg
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).
European journal of cancer (Oxford, England : 1990) 1999;35(1):54-9.
1998: John M H de Klerk; Bernard A Zonnenberg; AW Huiskes; S H Han; Geert H Blijham; Peter P van Rijk
[Palliative treatment of bone metastases with bone-seeking radionuclides].
Nederlands tijdschrift voor geneeskunde 1998;142(48):2618-22.
1998: Jacques A Wils; TM Sahmoud; A Sobrero; Harry Bleiberg; S Ahmedzai; J Blazeby; Geert H Blijham; T Conroy; D Cunningham; Desmond Curran; E Díaz-Rubio; M Ducreux; J Evans; B Glimelius; G Hutchinson; D Kerr; GM Kiebert; H Köhne; Roberto Labianca; R Langendijk; Donato Nitti; B Nordlinger; P Rougier; W Scheithauer; P Therasse
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.
Tumori 1998;84(3):335-47.
1997: S M Hellwig; CA Damen; N P van Adrichem; Geert H Blijham; Gerard Groenewegen; Arjan W Griffioen
Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors.
Cancer letters 1997;120(2):203-11.
1997: Pierre Hupperets; L Volovics; Leo J Schouten; Jos J Jager; Harry C Schouten; H F P Hillen; Geert H Blijham
The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer.
American journal of clinical oncology 1997;20(6):546-51.
1997: M Los; Colinda J Aarsman; L Terpstra; D Wittebol-Post; Cornelis J M Lips; Geert H Blijham; Emile E Voest
Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(10):1015-22.
1997: Harry Bleiberg; Béatrice Gerard; Jacques A Wils; Geert H Blijham; E Diaz-Rubio; Richard Herrmann; D Kerr; R Labianca; Philippe Rougier; H J Wilke; N Wilking
Gastrointestinal Tract Cancer Liaison Office: an attempt to organise clinical research in Europe.
European journal of cancer (Oxford, England : 1990) 1997;33(10):1536-45.
1997: Arjan W Griffioen; Marieke Coenen; CA Damen; S M Hellwig; D H van Weering; W Vooys; Geert H Blijham; Gerard Groenewegen
CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells.
Blood 1997;90(3):1150-9.
1997: Harry Bleiberg; Thierry Conroy; Bernard Paillot; AJ Lacave; Geert H Blijham; Jacques-Henri Jacob; Laurent Bedenne; M Namer; P De Besi; F Gay; L Collette; TM Sahmoud
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1216-20.
1997: Geert H Blijham; R Labianca; Harry Bleiberg
Should patients with advanced colorectal cancer be treated with chemotherapy?
European journal of cancer (Oxford, England : 1990) 1997;33(6):815-24.
1997: John M H de Klerk; Bernard A Zonnenberg; Geert H Blijham; Alfred D van het Schip; Anne Hoekstra; S H Han; JM Quirijnen; Aalt van Dijk; Peter P van Rijk
Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDP.
Anticancer research 1997;17(3B):1773-7.
1997: Leo J Schouten; Pierre Hupperets; Jos J Jager; L Volovics; Jacques A Wils; André L M Verbeek; Geert H Blijham
Prognostic significance of etiological risk factors in early breast cancer.
Breast cancer research and treatment 1997;43(3):217-23.
1997: RI Lalisang; Jacques A Wils; H W Nortier; J T Burghouts; Pierre Hupperets; F L G Erdkamp; Harry C Schouten; Geert H Blijham
Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1367-76.
1997: P J van de Ven; Paul Chr De Jong; G H Jansen; Geert H Blijham
[Microscopic tumor embolisms in metastasized breast carcinoma].
Nederlands tijdschrift voor geneeskunde 1997;141(11):536-40.
1996: A M Moers; R M Landsvater; C Schaap; J M Jansen-Schillhorn van Veen; I A de Valk; Geert H Blijham; Jo W M Höppener; T M Vroom; H K van Amstel; Cornelis J M Lips
Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
The American journal of medicine 1996;101(6):635-41.
1996: J M Quirijnen; S H Han; Bernard A Zonnenberg; John M H de Klerk; Alfred D van het Schip; Aalt van Dijk; H F ten Kroode; Geert H Blijham; Peter P van Rijk
Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1511-5.
1996: M Los; G H Jansen; William G Kaelin; Cornelis J M Lips; Geert H Blijham; Emile E Voest
Expression pattern of the von Hippel-Lindau protein in human tissues.
Laboratory investigation; a journal of technical methods and pathology 1996;75(2):231-8.
1996: Arjan W Griffioen; CA Damen; Geert H Blijham; Gerard Groenewegen
Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium.
Blood 1996;88(2):667-73.
1996: JP Simons; N K Aaronson; Johan Vansteenkiste; Guul P M ten Velde; M J Muller; B M Drenth; F L Erdkamp; E G Cobben; E J Schoon; J B Smeets; Harry C Schouten; M Demedts; H F Hillen; Geert H Blijham; Emiel F M Wouters
Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1077-84.
1996: John M H de Klerk; Bernard A Zonnenberg; H G Krouwer; Geert H Blijham; Aalt van Dijk; Alfred D van het Schip; J van Die; Peter P van Rijk
Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(3):465-7.
1996: Arjan W Griffioen; CA Damen; S Martinotti; Geert H Blijham; Gerard Groenewegen
Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors.
Cancer research 1996;56(5):1111-17.
1996: John M H de Klerk; Alfred D van het Schip; Bernard A Zonnenberg; Aalt van Dijk; J M Quirijnen; Geert H Blijham; Peter P van Rijk
Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(2):244-9.
1996: Elisabeth G E de Vries; S Rodenhuis; H C Schouten; Pierre Hupperets; Wil Dolsma; J V Lebesque; Geert H Blijham; M Bontenbal; Nanno H Mulder
Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer.
Breast cancer research and treatment 1996;39(3):307-13.
1996: Arjan W Griffioen; CA Damen; Geert H Blijham; Gerard Groenewegen
Endoglin/CD 105 may not be an optimal tumor endothelial treatment target.
Breast cancer research and treatment 1996;39(2):239-42.
1996: John M H de Klerk; E B van Dieren; Alfred D van het Schip; Anne Hoekstra; Bernard A Zonnenberg; Aalt van Dijk; D H Rutgers; Geert H Blijham; Peter P van Rijk
Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):38-41.
1995: Cornelis J M Lips; R M Landsvater; Jo W M Höppener; R A Geerdink; Geert H Blijham; J M Jansen-Schillhorn van Veen; M A Feldberg; A P van Gils; H Hoogenboom; M J Berends
From medical history and biochemical tests to presymptomatic treatment in a large MEN 2A family.
Journal of internal medicine 1995;238(4):347-56.
1995: Jos J Jager; J A Langendijk; J P Dohmen; I L Schreutelkamp; L Volovics; J M van Engelshoven; J M B V de Jong; Leo J Schouten; Pierre Hupperets; Geert H Blijham
Mammography in the follow-up after breast-conserving treatment in cancer of the breast: suitability for mammographic interpretation, validity and interobserver variation.
The British journal of radiology 1995;68(811):754-60.
1995: M M Tinnemans; Marie-Hélène Lenders; Guul P M ten Velde; Geert H Blijham; Frans C S Ramaekers; Bert Schutte
S-phase arrest of nutrient deprived lung cancer cells.
Cytometry 1995;19(4):326-33.
1995: M M Tinnemans; Marie-Hélène Lenders; Guul P M ten Velde; S S Wagenaar; Geert H Blijham; Frans C S Ramaekers; Bert Schutte
Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.
Virchows Archiv : an international journal of pathology 1995;427(3):295-301.
1994: John M H de Klerk; Bernard A Zonnenberg; Alfred D van het Schip; Aalt van Dijk; S H Han; J M Quirijnen; Geert H Blijham; Peter P van Rijk
Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer.
European journal of nuclear medicine 1994;21(10):1114-20.
1994: Cornelis J M Lips; R M Landsvater; Jo W M Höppener; R A Geerdink; Geert H Blijham; J M van Veen; A P van Gils; MJ de Wit; R A Zewald; M J Berends
Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
The New England journal of medicine 1994;331(13):828-35.
1994: John M H de Klerk; Alfred D van het Schip; Bernard A Zonnenberg; Aalt van Dijk; MP Stokkel; S H Han; Geert H Blijham; Peter P van Rijk
Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(9):1423-8.
1994: F L Erdkamp; Harry C Schouten; WP Breed; Willy C M Janssen; J J Hoffmann; Bert Schutte; Geert H Blijham
DNA aneuploidy in Hodgkin's disease: a multiparameter flow cytometric analysis.
Leukemia & lymphoma 1994;12(3-4):297-306.
1994: F L Erdkamp; Harry C Schouten; WP Breed; Willy C M Janssen; J J Hoffmann; M Reynders; Bert Schutte; Geert H Blijham
Comparison of image (CAS 200) and flow cytometry determined DNA content of paraffin-embedded Hodgkin's disease tissue.
Hematologic pathology 1994;8(3):75-84.
1994: Pierre Hupperets; Bert Schutte; C van Assche; Leo J Schouten; Jos J Jager; J de Jong; Geert H Blijham
Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases.
Breast cancer research and treatment 1994;32(2):197-202.
1993: M F Gnant; Geert H Blijham; A Reiner; M Schemper; M Reynders; Bert Schutte; C van Asche; G Steger; Raimund Jakesz
Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(8):643-50.
1993: M M Tinnemans; Bert Schutte; Marie-Hélène Lenders; Guul P M ten Velde; Frans C S Ramaekers; Geert H Blijham
Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling.
British journal of cancer 1993;67(6):1217-22.
1993: F L Erdkamp; M J Houben; WP Breed; Harry C Schouten; F H Wesseling; F J Jurgens; Geert H Blijham
The reliability and value of determining mediastinal involvement and width on chest radiographs in patients with Hodgkin's disease.
European journal of radiology 1993;16(2):143-6.
1993: F L Erdkamp; WP Breed; Harry C Schouten; Willy C M Janssen; J J Hoffmann; J T Wijnen; Geert H Blijham
DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(1):75-80.
1992: Pierre Hupperets; M G Havenith; Geert H Blijham
Recurrent adult nephroblastoma. Long-term remission after surgery plus adjuvant high-dose chemotherapy, radiation therapy, and allogeneic bone marrow transplantation.
Cancer 1992;69(12):2990-2.
1992: M F Gnant; Geert H Blijham; A Reiner; G Reiner; M Reynders; Bert Schutte; C van Asche; G Steger; Raimund Jakesz
DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study.
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):711-6.
1991: Pierre Hupperets; M M Fickers; Leo J Schouten; Geert H Blijham
A phase II study with mitomycin and vindesine in metastatic pretreated breast cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(4):520-1.
1991: Pierre Hupperets; G P ten Velde; H Bron; Leo J Schouten; Geert H Blijham
A phase II study of vindesine plus etoposide in metastatic non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(5):674-5.
1990: H Verhagen; C Furnée; Bert Schutte; F T Bosman; Geert H Blijham; P T Henderson; F ten Hoor; Jos C S Kleinjans
Dose-dependent effects of short-term dietary administration of the food additive butylated hydroxyanisole on cell kinetic parameters in rat gastro-intestinal tract.
Carcinogenesis 1990;11(9):1461-8.
1990: Geert H Blijham; H Bleiberg; N Duez; Marc Buyse
An EORTC phase II study of sequential methotrexate-fluorouracil in locally advanced or metastatic gastric cancer. The EORTC Gastrointestinal Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1990;26(1):63-5.
1989: H Verhagen; C Furnée; Bert Schutte; R J Hermans; F T Bosman; Geert H Blijham; F ten Hoor; P T Henderson; Jos C S Kleinjans
Butylated hydroxyanisole-induced alterations in cell kinetic parameters in rat forestomach in relation to its oxidative cytochrome P-450-mediated metabolism.
Carcinogenesis 1989;10(10):1947-51.
1989: Raimund Jakesz; G Reiner; M Schemper; A Reiner; Geert H Blijham; H Rainer; D Dittrich; J Spona; Bert Schutte; M Reynders
Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():180-5.
1988: H Verhagen; Bert Schutte; M M Reynders; Geert H Blijham; F ten Hoor; Jos C S Kleinjans
Effect of short-term dietary administration of butylated hydroxyanisole on cell kinetic parameters in rat gastro-intestinal tract, assessed by immunocytochemistry and flow cytometry.
Carcinogenesis 1988;9(6):1107-9.
1988: Guul P M ten Velde; Bert Schutte; A Vermeulen; A Volovics; M M Reynders; Geert H Blijham
Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer.
European journal of cancer & clinical oncology 1988;24(3):455-60.
1987: Bert Schutte; M M Reynders; Fred T Bosman; Geert H Blijham
Effect of tissue fixation on anti-bromodeoxyuridine immunohistochemistry.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1987;35(11):1343-5.
1987: Bert Schutte; M M Reynders; T Wiggers; Jan-Willem Arends; L Volovics; Fred T Bosman; Geert H Blijham
Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma.
Cancer research 1987;47(20):5494-6.
1987: Bert Schutte; M M Reynders; C L van Assche; Pierre Hupperets; Fred T Bosman; Geert H Blijham
An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry.
Cytometry 1987;8(4):372-6.
1987: Guul P M ten Velde; L H Greve; Geert H Blijham
Cisplatin and cytarabine combination chemotherapy of advanced non-small cell lung cancer: a pilot study.
European journal of cancer & clinical oncology 1987;23(5):581-2.
1987: Bert Schutte; M M Reynders; Fred T Bosman; Geert H Blijham
Studies with anti-bromodeoxyuridine antibodies: II. Simultaneous immunocytochemical detection of antigen expression and DNA synthesis by in vivo labeling of mouse intestinal mucosa.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1987;35(3):371-4.
1986: Jacques A Wils; Geert H Blijham; A Naus; C Belder; F Boschma; H Bron; T Ceelen; A Eekhout; J von Erp; P Geelen
Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(7):1068-73.
1986: Guul P M ten Velde; Emiel F M Wouters; L H Greve; A Vermeulen; A H Keijser; Geert H Blijham
Alternating chemotherapy, prophylactic cranial irradiation and late local thoracic irradiation for small-cell lung cancer.
Respiration; international review of thoracic diseases 1986;49(3):216-21.
1985: Bert Schutte; M M Reynders; Fred T Bosman; Geert H Blijham
Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue.
Cytometry 1985;6(1):26-30.